Maria Caterina Turco received her MD (magna cum laude) from Federico II University in 1980, her Master’s Degree in Clinical Biochemistry and PhD in Molecular Biology and Pathology from the same institution in, respectively, 1984 and 1988, and is currently serving as Full Professor of Biochemistry at the Department of Medicine and Surgery of the Salerno University. With extensive international experience as visiting professor at the New York Medical College of Valhalla, New York, the Memorial Sloan-Kettering Cancer Center of New York and the German Center for Cancer Research at Heidelberg, Prof. Turco has authored more than 140 peer-reviewed publications in prestigious journals such as Nature Communications, PNAS, Blood, Clinical Cancer Research. Her research topics mainly focus on molecules and mechanisms of intercellular signaling and the BAG3 protein and its biological activities As C.E.O. of the Academic spin-off FIBROSYS, she has successfully bridged academic research and biotechnology commercialization.
Maria Caterina Turco received her MD (magna cum laude) from Federico II University in 1980, her Master’s Degree in Clinical Biochemistry and PhD in Molecular Biology and Pathology from the same institution in, respectively, 1984 and 1988, and is currently serving as Full Professor of Biochemistry at the Department of Medicine and Surgery of the Salerno University. With extensive international experience as visiting professor at the New York Medical College of Valhalla, New York, the Memorial Sloan-Kettering Cancer Center of New York and the German Center for Cancer Research at Heidelberg, Prof. Turco has authored more than 140 peer-reviewed publications in prestigious journals such as Nature Communications, PNAS, Blood, Clinical Cancer Research. Her research topics mainly focus on molecules and mechanisms of intercellular signaling and the BAG3 protein and its biological activities As C.E.O. of the Academic spin-off FIBROSYS, she has successfully bridged academic research and biotechnology commercialization.